Why is GHK-Cu so hard to place? Because the whole field describes compounds by the wrong axis. Every intervention is a verb acting on a target — and once you separate those two questions, every peptide drops into a clear slot, and the areas most often missed — including one that rarely gets named — come into focus.
The reason GHK-Cu, BPC-157, and the rest feel impossible to file is that you're asking one question when there are two. "Where does this sit?" secretly bundles together what does it do and what does it act on — and those are different axes. A compound is a verb (an action) applied to a target (a tissue or system). Confuse the two and everything blurs into vague "cellular health." Separate them and it becomes a grid you can actually navigate. Let's build the grid — starting with the four verbs.
At the cellular level, essentially every intervention does one of four things. They form a spectrum from subtractive (removing) to additive (adding):
Clears out damaged components and cells — worn mitochondria (mitophagy), junk proteins (autophagy), zombie cells (senolysis). Fasting, Urolithin A, spermidine, fisetin.
Defends existing structures from damage — antioxidants, membrane stabilizers, anti-inflammatories. Glutathione, omega-3, methylene blue, SS-31, KPV.
Fixes and rebuilds damaged tissue — wound healing, gut lining, tendon, collagen scaffolding. GHK-Cu, BPC-157, TB-500.
Grows new capacity — muscle, mitochondria, tissue. Driven by mTOR / IGF-1 signaling. Protein, creatine, resistance training, growth hormone.
These are modes, not systems. A verb still needs a target. "Repair" isn't a place — it's an action that can act on your gut, your tendons, or your skin. So the full answer to "where does GHK-Cu sit?" has two parts: it's a Repair verb, acting on the connective-tissue / skin target. Name both, and there's no more confusion.
Here's the full list, each split into its verb and its target. Notice how the peptides usually filed under "cleanup" are almost all actually repair or protect:
| Compound | Verb | Target | Evidence |
|---|---|---|---|
| GHK-Cu (copper) | Repair | Connective tissue / skin (collagen, remodeling) | Emerging |
| BPC-157 | Repair | Gut lining, tendon, blood vessels | Animal |
| TB-500 | Repair | Connective tissue, muscle (regeneration) | Animal |
| KPV | Protect | Gut (calms inflammation) | Animal |
| SS-31 (elamipretide) | Protect | Mitochondria (membrane stabilizer) | Emerging |
| Thymosin α-1 | Regulate | Immune system (see below) | Emerging+ |
| Urolithin A | Clean | Mitochondria (mitophagy) | Human |
| Spermidine | Clean | Whole cell (autophagy) | Human |
| Fisetin / quercetin | Clean | Senescent cells (senolytic) | Emerging |
| FOXO4-DRI | Clean | Senescent cells (senolytic) | Frontier |
| Epitalon / Pinealon | Signal | Genome/telomeres · brain (not cleanup) | Frontier |
Of the compounds usually named, only Urolithin A, spermidine, and the senolytics actually clean. GHK-Cu, BPC-157, and TB-500 are repair (rebuild damaged tissue); KPV and SS-31 are protect (shield). The peptide market lumps all of these under "renewal," but rebuilding a torn tendon and digesting a worn-out mitochondrion are opposite operations. If these have all read as "cleanup," that is the field's confusion rather than the reader's.
That is exactly the right question to ask. Cleanup is not just about mitochondria — it has three distinct sub-jobs, and a complete "clean" strategy covers all three:
Mitophagy clears worn-out mitochondria specifically — this is the Urolithin A lane, and it's the one most closely tied to the mitochondrial material.
Autophagy is the broader cleanup — clearing misfolded proteins and cellular debris throughout the whole cell, not just mitochondria. This is the fasting and spermidine lane, and it's the biggest of the three.
Senolysis clears entire zombie cells — senescent cells that have stopped working but linger and leak inflammation into their neighbors. This is the fisetin / (frontier) FOXO4-DRI lane.
"Cleaning" isn't one job — it's three: mitophagy, autophagy, and senescence clearance. The good news is that the master lever — fasting / lowering the build signal — switches on the first two together, and diet plus fisetin addresses the third. One behavioral change opens most of the door.
Thymosin α-1 comes up often enough to be worth placing properly. First, clear up a naming trap: thymosin α-1 and thymosin β-4 (TB-500) are different peptides that share a family name. TB-500 is a repair peptide (tissue). Thymosin α-1 is an immune-regulating peptide — it strengthens and balances T-cell function. Same "thymosin," opposite jobs.
And that points to a target few protocols build for explicitly: the immune system. As we age, immune function drifts — weaker defense plus more background inflammation (a process called immunosenescence). It's a legitimate longevity domain in its own right.
Most well-built protocols cover immune foundations incidentally — zinc, vitamin D, glutathione, sleep, exercise and anything that lowers background inflammation all support immunity. So it is rarely an empty column the way cleanup is. Thymosin α-1 is the dedicated immune tool (it has real clinical use in some countries for immune support, more evidence than most gray-market peptides, though still investigational or compounded in others). The honest read: name immune as a domain and keep the foundations strong, but it is a lower-priority gap than cleanup — worth knowing exists, not worth leading with.
Putting it together — here is the full set of target domains, with the coverage a typical well-built protocol achieves in each. This is the whole territory:
Every compound is a verb (clean, protect, repair, build) acting on a target (gut, mitochondria, connective tissue, immune…). The peptides usually filed under "cleanup" are mostly repair (GHK-Cu, BPC-157, TB-500) or protect (SS-31, KPV) in disguise; real cleaning is three jobs (mitophagy, autophagy, senescence) led by fasting plus Urolithin A, spermidine, and fisetin; and the domain most often covered only by accident is immune — worth naming, lower priority than cleanup.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Many peptides referenced (BPC-157, TB-500, KPV, GHK-Cu, thymosin α-1, Epitalon, Pinealon, FOXO4-DRI) are investigational, unapproved in many jurisdictions, or gray-market, with evidence ranging from human trials to animal-only, and carry sourcing and safety considerations. Fasting and senolytic approaches interact with medications, training, and individual health status. Nothing here is a recommendation to use any compound; decisions belong with a qualified physician who knows your full situation.
A visual guide to how metabolism, mitochondria, hormones, sleep, muscle, the heart, the gut and the brain influence one another — the whole system on one page, with the strongest connections written out. Use it as your roadmap while you work through the lessons.
Free. The map is yours to keep. Plus occasional new lessons and evidence-based updates. No spam. Unsubscribe any time.
This lesson relates to these health systems — health works as a connected system, not isolated topics.
Free to download right now — no email needed:
The Health Map — a visual guide to how metabolism, mitochondria, hormones, sleep, muscle, the heart, the gut and the brain influence one another. Every lesson on the site stays free to read either way.
Free. No spam, unsubscribe any time.
Health makes more sense when more than one person is looking at it. Everything here is free to read.
Want the rest? The foundation bundles collect these lessons into one file, free.
